Eleos Health lands about $ 20M health

Eleos Health has announced the launch of a $ 20 million Around Health Series for its AI -assisted voice technology gathers information about a patient’s mental health. This new round of funding comes more than a year after Boston and Tel Aviv startups announced a $ 6 million round of revenue, bringing the total increase to $ 28 million. .

F-Prime Capital and Eight Roads Ventures led the circle with input from a Moon Fund, lool ventures and Arkin Holdings.


The company has developed a smart voice device that can run after a mental health session. Physicians can use the platform’s AI capabilities to help monitor their patients.

The manufacturer can provide information on key words or topics of conversation, use of medical techniques such as CBT the seasons and the amount of time the doctor spent talking vs. the sick. Customers can click on the app to learn more about general care coverage and patient improvement scores, according to the company.

Eleos technology is covered on top of suppliers ’EHRs and can be used in telehealth and brick-and-mortar settings.


Although the company did not explain how the new funds would be used, it planned to grow its site in usage and size. The agency said it captured 6.5 million minutes of maintenance and expects to capture 30 million minutes by the end of the year.

“Eleos Health offers an independent approach, by combining the power of voice and Natural Language Understanding, with occupational safety and compliance with standards in the workplace. to lead to better results and to reduce burnout, ”Carl Byers, partner at F-Prime Capital, said in a statement.

“We look forward to working with this talented team as they work on future ways to grow the industry.”


This isn’t the only mental health industry looking to incorporate audio technology into their offerings. Mindstrong, a mental health startup that uses digital biomarkers, with Voice, will have $ 100 million by 2020.

In addition, Kintsugi, a site that uses audio biomarkers to diagnose anxiety and depression, received $ 8 million in product funding last year and about $ 20 million in Series A funding in February. .

Related Posts

Leave a Reply

Your email address will not be published.